NCT02504125View on ClinicalTrials.gov

The Efficacy and Safety of Using Tranexamic Acid to Reduce Blood Loss In Simultaneous Bilateral Total Knee Arthroplasty

PHASE4CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2015

Conditions
Blood Loss
Interventions
DRUG

Tranexamic Acid

1 g of tranexamic acid in 100 mL of normal saline intravenously approximately 15 minutes before incision

DRUG

Normal saline

100 mL of normal saline intravenously approximately 15 minutes before incision

Trial Locations (1)

710032

Xijing hospital, Xi'an

All Listed Sponsors
lead

Xijing Hospital

OTHER

NCT02504125 - The Efficacy and Safety of Using Tranexamic Acid to Reduce Blood Loss In Simultaneous Bilateral Total Knee Arthroplasty | Biotech Hunter | Biotech Hunter